Have your say on the draft guidance for replication competent virus assays

Published: 6 December 2024

Our consultation on best practice guidance on replication competent virus assays is open until 28 February 2025.

We would like to hear your views about the value and content of this guideline, as well as any feedback you have about similar work that would further support the quality and development of cell and gene therapies.  

To find out more and contribute, read more about the consultation: 
https://www.pharmacopoeia.com/draft-guidance-replication-competent-virus-assays